Severe active co-morbidity as determined by the investigator or principal investigator
Severe, active co-morbidity, defined as follows:
Severe, active co-morbidity, defined as follows:
Severe, active co-morbidity
Severe, active co-morbidity defined as follows:\r\n* Life expectancy <  months
Severe or uncontrolled concurrent disease, infection or co-morbidity.
Patients with severe, active co-morbidity, defined as follows:
Severe, active co-morbidity
Severe, active co-morbidity, defined as follows:
Sorrors co-morbidity factors with total score > 
Sorror co-morbidity index > 
Sorrors co-morbidity factors with total score > 
Sorrors co-morbidity factors with total score >= \r\n* Important modification to co-morbidity index calculation: DLCO adjusted will not be included in assessment of pulmonary risk, except those patients with DLCO adjusted < % who are excluded from the trial
Severe, active co-morbidity, defined as follows:
